The role of ELSIE in evolving current thinking on extractables and leachables

References

1. ICH Assembly, Singapore. November 2019. Available at: https://www.ich.org/pressrelease/ich-assembly-singapore-november-2019. [Accessed 27 December 2019].
2. Nagao et al. The ELSIE Extractable and Leachable Database [Internet]. Pharm. Outsourcing. 01 November 2011. Available at: https://www.pharmoutsourcing.com/Featured-Articles/37828-The-ELSIE-Extractables-and-Leachables-Database/. [Accessed on 27 Dec 2019].
3. Teasdale et al. Controlled Extraction Studies Applied to Polyvinyl Chloride and Polyethylene Materials: Conclusions from the ELSIE Controlled Extraction Pilot Study. AAPS PharmSciTech. 16(3), 2015, 664-674.
4. Stults et al. Evaluation of extractables in processed and unprocessed polymer materials used for pharmaceutical applications. AAPS PharmSciTech. 16)1), 2015, 150-164.
5. ICH Q3D, 2014. Guideline for elemental impurities – Step 4. 16 December 2014.
6. Jenke et al. Materials in Manufacturing and Packaging Systems as Sources of Elemental Impurities in Packaged Drug Products: A Literature Review. PDA Pharm. Sci. Technol. 69(1), 2015, 1-48.
7. Broschard et al. Assessing safety of extractables from materials and leachables in pharmaceuticals and biologics – Current challenges and approaches. Toxicol. Pharmacol., 81, 2016, 201-211.
8. Norwood et al. Best practices for extractables and leachables in orally inhaled and nasal drug products: An overview of the PQRI recommendations. Res., 25(4), 2007, 727-739.
9. ICH M7. Guideline on assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk – Step 4. 23 June 2014.
10. Extractables and leachables– safety-based limits. EPR, 22(4), 2017, 7.
11. Joint Pharmaceutical Analysis Group symposium entitled ICH Q3E (Extractables and Leachables): setting the scene. Thursday 7 May 2020. Available at: https://www.jpag.org/.